CAS: 418805-02-4 - PYR-41
Formula:C17H13N3O7
InChI:InChI=1S/C17H13N3O7/c1-2-26-17(23)10-3-5-11(6-4-10)19-16(22)13(15(21)18-19)9-12-7-8-14(27-12)20(24)25/h3-9H,2H2,1H3,(H,18,21)
InChI key:InChIKey=ARGIPZKQJGFSGQ-UHFFFAOYSA-N
SMILES:O=C(OCC)C1=CC=C(C=C1)N2NC(=O)C(=CC=3OC(=CC3)N(=O)=O)C2=O
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | PYR 41 REF: AN-AG00C6HJCAS: 418805-02-4 | 98+% | 61.00 €~667.00 € | Mon 29 Apr 24 |
 | PYR-41 REF: TM-T6629CAS: 418805-02-4 | 98% | 39.00 €~1,003.00 € | Mon 06 May 24 |
 | PYR-41 REF: TR-P840380CAS: 418805-02-4 | - - - | 80.00 €~259.00 € | Thu 09 May 24 |
 | PYR 41 REF: 3D-TRA80502CAS: 418805-02-4 | Min. 95% | 97.00 €~483.00 € | Fri 10 May 24 |
Ref: AN-AG00C6HJ
| 5mg | 61.00 € | |
| 10mg | 81.00 € | |
| 50mg | 224.00 € | |
| 100mg | 474.00 € | |
| 250mg | 667.00 € |
Estimated delivery in United States, on Monday 29 Apr 2024
PYR-41
CAS:418805-02-4
PYR-41 is the first cell-permeable inhibitor of ubiquitin-activating enzyme E1, with no activity at E2.
Formula:
C17H13N3O7
Purity:
98%
Color and Shape:
Solid
Molecular weight:
371.3
Ref: TM-T6629
| 2mg | 39.00 € | |
| 5mg | 57.00 € | |
| 10mg | 85.00 € | |
| 25mg | 160.00 € | |
| 50mg | 304.00 € | |
| 100mg | 463.00 € | |
| 200mg | 638.00 € | |
| 500mg | 1,003.00 € | |
| 1ml*10 (DMSO) | 63.00 € |
Estimated delivery in United States, on Monday 6 May 2024
PYR-41
CAS:418805-02-4
Applications PYR-41 is the cell-permeable inhibitor of ubiquitin-activating enzyme E1, with no activity at E2. …
Formula:
C17H13N3O7
Color and Shape:
Dark Red Solid
Molecular weight:
371.30
Ref: TR-P840380
| 1mg | 80.00 € | |
| 5mg | 89.00 € | |
| 25mg | 259.00 € |
Estimated delivery in United States, on Thursday 9 May 2024
PYR 41
CAS:418805-02-4
PYR 41 is a small molecule that inhibits the activity of the ATP-binding cassette (ABC) …
Formula:
C17H13N3O7
Purity:
Min. 95%
Molecular weight:
371.3 g/mol
Ref: 3D-TRA80502
| 5mg | 97.00 € | |
| 10mg | 143.00 € | |
| 25mg | 232.00 € | |
| 50mg | 339.00 € | |
| 100mg | 483.00 € |
Estimated delivery in United States, on Friday 10 May 2024
